# Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

> **NCT02101138** · PHASE2 · UNKNOWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 15 (actual)

## Conditions studied

- Hypereosinophilic Syndrome

## Interventions

- **DRUG:** Dexpramipexole

## Key facts

- **NCT ID:** NCT02101138
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03-14
- **Primary completion:** 2016-12-30
- **Final completion:** 2019-10-23
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101138, "Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02101138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*